Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
EMA
1551
Emera Inc
EMA
$14.8B
| $12M | ﹤0.01% |
242,709
+119,443
| +97% | +$5.77M |
2025 Q2
2 quarters
|
|
1552
PUT
First Horizon
FHN
$11.1B
| $11.9M | ﹤0.01% |
+500,000
| New | +$11.1M |
2025 Q4
0 quarters
|
|
1553
Donaldson
DCI
$10.3B
| $11.9M | ﹤0.01% |
134,756
-44,792
| -25% | -$3.89M |
2013 Q2
50 quarters
|
|
|
1554
CALL
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.7B
| $11.9M | ﹤0.01% |
100,000
-100,000
| -50% | -$11.9M |
2025 Q3
1 quarter
|
|
1555
TAL Education Group
TAL
$6.69B
| $11.9M | ﹤0.01% |
1,094,352
+662,008
| +153% | +$7.52M |
2015 Q4
40 quarters
|
|
1556
Frontdoor
FTDR
$5.32B
| $11.9M | ﹤0.01% |
206,888
-57,411
| -22% | -$3.38M |
2018 Q4
28 quarters
|
|
1557
ICF International
ICFI
$1.47B
| $11.9M | ﹤0.01% |
139,609
+2,702
| +2% | +$229K |
2016 Q2
38 quarters
|
|
1558
Lithia Motors
LAD
$6.77B
| $11.9M | ﹤0.01% |
35,720
-8,053
| -18% | -$2.56M |
2013 Q2
50 quarters
|
|
1559
Cirrus Logic
CRUS
$6.07B
| $11.9M | ﹤0.01% |
100,098
-83,024
| -45% | -$10.2M |
2013 Q2
50 quarters
|
|
1560
Vanguard Total International Stock ETF
VXUS
$161B
| $11.8M | ﹤0.01% |
157,001
-20,313
| -11% | -$1.52M |
2020 Q2
22 quarters
|
|
1561
Brown-Forman Class B
BF.B
$12B
| $11.8M | ﹤0.01% |
454,349
-122,085
| -21% | -$3.44M |
2013 Q2
50 quarters
|
|
1562
ADMA Biologics
ADMA
$2.18B
| $11.8M | ﹤0.01% |
649,100
-114,846
| -15% | -$1.94M |
2018 Q1
31 quarters
|
|
1563
Charles River Laboratories
CRL
$13.9B
| $11.8M | ﹤0.01% |
59,134
-92,225
| -61% | -$16.7M |
2020 Q4
20 quarters
|
|
1564
PUT
JD.com
JD
$34.8B
| $11.8M | ﹤0.01% |
410,000
+156,600
| +62% | +$4.9M |
2024 Q3
5 quarters
|
|
1565
Innoviva
INVA
$1.48B
| $11.8M | ﹤0.01% |
588,529
+253,752
| +76% | +$4.96M |
2013 Q2
50 quarters
|
|
1566
CALL
Pan American Silver
PAAS
$18.9B
| $11.7M | ﹤0.01% |
+226,700
| New | +$9.49M |
2025 Q4
0 quarters
|
|
1567
Nutrien
NTR
$33.4B
| $11.7M | ﹤0.01% |
190,233
+37,046
| +24% | +$2.18M |
2018 Q1
31 quarters
|
|
1568
Integer Holdings
ITGR
$4.3B
| $11.6M | ﹤0.01% |
148,357
+28,411
| +24% | +$2.26M |
2016 Q3
37 quarters
|
|
1569
PUT
Ionis Pharmaceuticals
IONS
$7.24B
| $11.6M | ﹤0.01% |
146,900
| – | – |
2024 Q3
5 quarters
|
|
1570
Paylocity
PCTY
$7.67B
| $11.6M | ﹤0.01% |
75,762
-11,458
| -13% | -$1.7M |
2014 Q2
46 quarters
|
|
1571
Graham Holdings Company
GHC
$4.87B
| $11.5M | ﹤0.01% |
10,511
-408
| -4% | -$436K |
2014 Q4
44 quarters
|
|
1572
Terreno Realty
TRNO
$7.03B
| $11.5M | ﹤0.01% |
196,539
+12,902
| +7% | +$777K |
2013 Q2
50 quarters
|
|
1573
Primoris Services
PRIM
$4.26B
| $11.5M | ﹤0.01% |
92,878
-7,946
| -8% | -$1.04M |
2016 Q3
37 quarters
|
|
1574
ICICI Bank
IBN
$98.5B
| $11.5M | ﹤0.01% |
386,815
+9,035
| +2% | +$277K |
2013 Q2
50 quarters
|
|
1575
e.l.f. Beauty
ELF
$6.18B
| $11.5M | ﹤0.01% |
151,427
+60,167
| +66% | +$5.92M |
2019 Q1
27 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.